Thrivent Financial for Lutherans »

Lineage Cell Therapeutics In shares owned by Thrivent Financial for Lutherans

Quarter-by-quarter ownership of Lineage Cell Therapeutics In (LCTX) shares owned by Thrivent Financial for Lutherans from 13F filings

Historical chart of Thrivent Financial for Lutherans investment in Lineage Cell Therapeutics In

Tip: Access up to 7 years of quarterly data

All positions including Lineage Cell Therapeutics In held by Thrivent Financial for Lutherans consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lineage Cell Therapeutics In by Thrivent Financial for Lutherans

Quarter filed Position value Share count Share price at filing
2024-03-31 $22k 15k 1.47
2023-09-30 $18k 15k 1.20
2023-06-30 $21k 15k 1.40
2023-03-31 $22k 15k 1.47
2022-12-31 $18k 15k 1.20
2022-09-30 $17k 15k 1.13
2021-09-30 $107k 43k 2.50
2021-06-30 $121k 43k 2.84